A carregar...
Nivolumab Induced Seronegative Arthritis in a Patient With Refractory Hodgkin’s Lymphoma
Nivolumab is a monoclonal antibody against programmed cell death protein-1 which is assessed in the group of immune checkpoint inhibitors. It may lead to immune-related adverse events. In this article, we report a 38-year-old male patient diagnosed with seronegative arthritis after nivolumab therapy...
Na minha lista:
| Publicado no: | Arch Rheumatol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Turkish League Against Rheumatism
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6542205/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5606/ArchRheumatol.2019.7041 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|